Janssen Research & Development proudly joins the Global Initiative for Asthma (GINA) in support of World Asthma Day, an annual event intended to improve asthma awareness and care for this difficult-to-treat, and potentially, life-threatening disease that affects more than 300 million people worldwide.
Janssen continues to advance the scientific understanding of the condition, and work towards the discovery, development and ultimately, the delivery of treatments for patients living with severe asthma. We are evaluating the heterogeneity of patients living with pulmonary disease to understand the underlying disease biology, seeking to provide better personalized treatment options no matter what the severity of the symptoms entails.
Our goal, together with internal and external collaboration partners, is to help people live a vibrant and healthy life, free from the debilitating symptoms associated with this life-altering disease.
You can learn more about this disease and our efforts – and share the information with others – in our latest infographic.